Key facts
- Zoundream’s last known valuation is $4.2M (Dec 2020).
- It has raised $6.6M; the latest was Seed Round ($4.7M) in Sep 2025.
- Notable investors include Endless Frontier Labs, Loyal VC, TQ Ventures, Verge Capital Management, Secways — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Zoundream
- ·The full record, as it builds
Funding rounds
No funding rounds for Zoundream are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zoundream
Developer of an infant cry analysis platform designed to monitor babies' health and development. The company's platform utilizes sound recognition and artificial intelligence integrated into baby monitors to interpret newborns' cries in real-time, detecting needs such as hunger or sleepiness, helping parents and healthcare providers better understand infants and identify potential health issues early.
- Sector
- Healthcare
- HQ
- Barcelona, Spain
- Founded
- 2019
- Employees
- 18
- Website
- zoundream.com/
- Ownership
- Privately Held (backing)
Zoundream doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zoundream shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zoundream in its N-PORT filings yet. We sweep new filings monthly.